Review



ova peptide  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress ova peptide
    Ova Peptide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 20 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p1489a/OVA+Peptide/pmc13153610-247-12-17
    Average 94 stars, based on 20 article reviews
    ova peptide - by Bioz Stars, 2026-10
    94/100 stars

    Images

    Related Articles

    Recombinant:

    Article Title: Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies GAPDH Proteintech Cat# 60004-1-Ig; RRID:AB_2107436 PLOD2 Abcam Cat# ab313765 Cytokeratin 19 Aifang Cat# AFRM0054 CD31 Abcam Cat# ab281583; RRID:AB_3096925 Fibronectin Proteintech Cat# 66042-1-Ig; RRID:AB_11182385 S100A2 Proteintech Cat# 15454-1-AP; RRID:AB_3669209 GATA6 Proteintech Cat# 55435-1-AP; RRID:AB_11182815 Paxillin Proteintech Cat# 10029-1-Ig; RRID:AB_513929 Integrin β1 Aifang Cat# AFRM0070 alpha smooth muscle Abcam Cat# ab7817; RRID:AB_262054 FAP Proteintech Cat# 11779-1-AP; RRID:AB_3669133 DUSP6 Proteintech Cat# 26071-1-AP; RRID:AB_3669521 ANGPTL4 Proteintech Cat# 18374-1-AP; RRID:AB_2878539 NDRG1 Proteintech Cat# 26902-1-AP; RRID:AB_2880676 CD45 Abcam Cat# ab281586; RRID:AB_3697165 MCTP2 Proteintech Cat# 17578-1-AP; RRID:AB_2143118 CD3 Abcam Cat# ab16669; RRID:AB_443425 CD68 Abcam Cat# ab283654; RRID:AB_2922954 SYN Proteintech Cat# 17785-1-AP; RRID:AB_2271365 IGF1R Proteintech Cat# 20254-1-AP; RRID:AB_10667455 PPP2R2C Proteintech Cat# 12747-1-AP; RRID:AB_2170099 hCD45 BioLegend Cat# 304008; RRID:AB_314396 mCD45 BioLegend Cat# 103112; RRID:AB_312977 HLA-G Proteintech Cat# 66447-1-Ig anti-Myc-Tag Cell Signaling Technology Cat# 2278; RRID: AB_490778 anti-FLAG Cell Signaling Technology Cat# 14793; RRID: AB_2572291 anti-HA Abcam Cat #ab9110, RRID: AB_307019 Biological samples Human pancreatic cancer tissues This study N/A Patient-derived xenografts This study N/A Chemicals, peptides, and recombinant proteins PROTAC-G3 This study N/A Activin A MedChemExpress Cat# HY-P70311 MG-132 MedChemExpress Cat# HY-13259 Latrunculin A Abcam Cat# ab144290 KP-457 MedChemExpress Cat# HY-110397 Cycloheximide MedChemExpress Cat# HY-12320 (S)-ACE-OH MedChemExpress Cat# HY169325 OVA Peptide MedChemExpress Cat# HY-P1489 Recombinant Streptococcus pyogenes CRISPR-Cas9 Protein (His Tag) SinoBiological Cat: 40572-A08B (Continued on next page) ll OPEN ACCESSArticle Cancer Cell 44, 1–16.e1–e11, August 10, 2026 e1 .. REAGENT or RESOURCE SOURCE IDENTIFIER Critical commercial assays poly-L-lysine MedChemExpress Cat# HY-126437K Optimal Cutting Temperature (OCT) compound Solarbio Cat# I7830 Protease inhibitor cocktail Proteintech Cat# PR20032 HypoxyprobeTM-1 Natural Pharmacia International Cat# HP3-100Kit P3 Primary Cell 4D-Nucleofector X Unit Reagent Kit L LONZA LONZA-V4XP-3024 IFN-γ ELISpot Kit Dayo Cat#2210005 DAPI Dihydrochloride Proteintech 28718-90-3 Deposited data snRNA-seq data (human PDAC tissues) This study National Omics Data Encyclopedia, OEP00006497 RNA-seq data (cell lines) This study National Omics Data Encyclopedia, OEZ00021631 Xenium 5K data (human PDAC tissues) This study National Omics Data Encyclopedia, OEZ00021630 snRNA-seq data (human PDAC tissues with neoadjuvant treatment) Hwang et al.11 GSE202051 scRNA-seq data (human PDAC tissues, #1) Steele et al. GSE155698 scRNA-seq data (human PDAC tissues, #2) Peng et al.12 CRA001160 scRNA-seq data (human PDAC tissues, #3) Lin et al. GSE154778 Experimental models: Cell lines MIA PaCa-2 American Type Culture Collection CRL-1420 CFPAC-1 American Type Culture Collection CRL-1918 SW1990 American Type Culture Collection CRL-2172 PANC-1 American Type Culture Collection CRL-1469 αTC1-6 American Type Culture Collection CRL-2934 THP-1 American Type Culture Collection TIB-202 HUVEC American Type Culture Collection PCS-100-013 HPDE6-C7 Anwei-sci Cell Center AW-CH0777 KPC-0116 FUSCC https://doi.org/10.1016/j. xcrm.2023.101234 Patient-derived CAFs FUSCC https://doi.org/10.1016/j. csbj.2024.04.021.

    Article Title: Oat-β-glucan potentiates anti-PD-1 efficacy through Faecalibacterium prausnitzii-derived butyrate and indole-3-propionic acid.
    Article Snippet: In brief Yang et al. reveal that oat-β-glucan enhances anti-PD-1 efficacy in colorectal cancer via the F. prausnitzii-butyrate/ indole-3-propionic acid (IPA)-CD8 T cell and dendritic cell axis, which correlates with better efficacy in ICI-treated cohorts.. A human trial confirms that oat-β-glucan favorably modulates F. prausnitzii, butyrate, and IPA.. Detection efficacy Mouse model Subcutaneous tumor

    CRISPR:

    Article Title: Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies GAPDH Proteintech Cat# 60004-1-Ig; RRID:AB_2107436 PLOD2 Abcam Cat# ab313765 Cytokeratin 19 Aifang Cat# AFRM0054 CD31 Abcam Cat# ab281583; RRID:AB_3096925 Fibronectin Proteintech Cat# 66042-1-Ig; RRID:AB_11182385 S100A2 Proteintech Cat# 15454-1-AP; RRID:AB_3669209 GATA6 Proteintech Cat# 55435-1-AP; RRID:AB_11182815 Paxillin Proteintech Cat# 10029-1-Ig; RRID:AB_513929 Integrin β1 Aifang Cat# AFRM0070 alpha smooth muscle Abcam Cat# ab7817; RRID:AB_262054 FAP Proteintech Cat# 11779-1-AP; RRID:AB_3669133 DUSP6 Proteintech Cat# 26071-1-AP; RRID:AB_3669521 ANGPTL4 Proteintech Cat# 18374-1-AP; RRID:AB_2878539 NDRG1 Proteintech Cat# 26902-1-AP; RRID:AB_2880676 CD45 Abcam Cat# ab281586; RRID:AB_3697165 MCTP2 Proteintech Cat# 17578-1-AP; RRID:AB_2143118 CD3 Abcam Cat# ab16669; RRID:AB_443425 CD68 Abcam Cat# ab283654; RRID:AB_2922954 SYN Proteintech Cat# 17785-1-AP; RRID:AB_2271365 IGF1R Proteintech Cat# 20254-1-AP; RRID:AB_10667455 PPP2R2C Proteintech Cat# 12747-1-AP; RRID:AB_2170099 hCD45 BioLegend Cat# 304008; RRID:AB_314396 mCD45 BioLegend Cat# 103112; RRID:AB_312977 HLA-G Proteintech Cat# 66447-1-Ig anti-Myc-Tag Cell Signaling Technology Cat# 2278; RRID: AB_490778 anti-FLAG Cell Signaling Technology Cat# 14793; RRID: AB_2572291 anti-HA Abcam Cat #ab9110, RRID: AB_307019 Biological samples Human pancreatic cancer tissues This study N/A Patient-derived xenografts This study N/A Chemicals, peptides, and recombinant proteins PROTAC-G3 This study N/A Activin A MedChemExpress Cat# HY-P70311 MG-132 MedChemExpress Cat# HY-13259 Latrunculin A Abcam Cat# ab144290 KP-457 MedChemExpress Cat# HY-110397 Cycloheximide MedChemExpress Cat# HY-12320 (S)-ACE-OH MedChemExpress Cat# HY169325 OVA Peptide MedChemExpress Cat# HY-P1489 Recombinant Streptococcus pyogenes CRISPR-Cas9 Protein (His Tag) SinoBiological Cat: 40572-A08B (Continued on next page) ll OPEN ACCESSArticle Cancer Cell 44, 1–16.e1–e11, August 10, 2026 e1 .. REAGENT or RESOURCE SOURCE IDENTIFIER Critical commercial assays poly-L-lysine MedChemExpress Cat# HY-126437K Optimal Cutting Temperature (OCT) compound Solarbio Cat# I7830 Protease inhibitor cocktail Proteintech Cat# PR20032 HypoxyprobeTM-1 Natural Pharmacia International Cat# HP3-100Kit P3 Primary Cell 4D-Nucleofector X Unit Reagent Kit L LONZA LONZA-V4XP-3024 IFN-γ ELISpot Kit Dayo Cat#2210005 DAPI Dihydrochloride Proteintech 28718-90-3 Deposited data snRNA-seq data (human PDAC tissues) This study National Omics Data Encyclopedia, OEP00006497 RNA-seq data (cell lines) This study National Omics Data Encyclopedia, OEZ00021631 Xenium 5K data (human PDAC tissues) This study National Omics Data Encyclopedia, OEZ00021630 snRNA-seq data (human PDAC tissues with neoadjuvant treatment) Hwang et al.11 GSE202051 scRNA-seq data (human PDAC tissues, #1) Steele et al. GSE155698 scRNA-seq data (human PDAC tissues, #2) Peng et al.12 CRA001160 scRNA-seq data (human PDAC tissues, #3) Lin et al. GSE154778 Experimental models: Cell lines MIA PaCa-2 American Type Culture Collection CRL-1420 CFPAC-1 American Type Culture Collection CRL-1918 SW1990 American Type Culture Collection CRL-2172 PANC-1 American Type Culture Collection CRL-1469 αTC1-6 American Type Culture Collection CRL-2934 THP-1 American Type Culture Collection TIB-202 HUVEC American Type Culture Collection PCS-100-013 HPDE6-C7 Anwei-sci Cell Center AW-CH0777 KPC-0116 FUSCC https://doi.org/10.1016/j. xcrm.2023.101234 Patient-derived CAFs FUSCC https://doi.org/10.1016/j. csbj.2024.04.021.

    Virus:

    Article Title: Oat-β-glucan potentiates anti-PD-1 efficacy through Faecalibacterium prausnitzii-derived butyrate and indole-3-propionic acid.
    Article Snippet: In brief Yang et al. reveal that oat-β-glucan enhances anti-PD-1 efficacy in colorectal cancer via the F. prausnitzii-butyrate/ indole-3-propionic acid (IPA)-CD8 T cell and dendritic cell axis, which correlates with better efficacy in ICI-treated cohorts.. A human trial confirms that oat-β-glucan favorably modulates F. prausnitzii, butyrate, and IPA.. Detection efficacy Mouse model Subcutaneous tumor

    Control:

    Article Title: Oat-β-glucan potentiates anti-PD-1 efficacy through Faecalibacterium prausnitzii-derived butyrate and indole-3-propionic acid.
    Article Snippet: In brief Yang et al. reveal that oat-β-glucan enhances anti-PD-1 efficacy in colorectal cancer via the F. prausnitzii-butyrate/ indole-3-propionic acid (IPA)-CD8 T cell and dendritic cell axis, which correlates with better efficacy in ICI-treated cohorts.. A human trial confirms that oat-β-glucan favorably modulates F. prausnitzii, butyrate, and IPA.. Detection efficacy Mouse model Subcutaneous tumor

    Modification:

    Article Title: Oat-β-glucan potentiates anti-PD-1 efficacy through Faecalibacterium prausnitzii-derived butyrate and indole-3-propionic acid.
    Article Snippet: In brief Yang et al. reveal that oat-β-glucan enhances anti-PD-1 efficacy in colorectal cancer via the F. prausnitzii-butyrate/ indole-3-propionic acid (IPA)-CD8 T cell and dendritic cell axis, which correlates with better efficacy in ICI-treated cohorts.. A human trial confirms that oat-β-glucan favorably modulates F. prausnitzii, butyrate, and IPA.. Detection efficacy Mouse model Subcutaneous tumor

    HDAC Activity Assay:

    Article Title: Oat-β-glucan potentiates anti-PD-1 efficacy through Faecalibacterium prausnitzii-derived butyrate and indole-3-propionic acid.
    Article Snippet: In brief Yang et al. reveal that oat-β-glucan enhances anti-PD-1 efficacy in colorectal cancer via the F. prausnitzii-butyrate/ indole-3-propionic acid (IPA)-CD8 T cell and dendritic cell axis, which correlates with better efficacy in ICI-treated cohorts.. A human trial confirms that oat-β-glucan favorably modulates F. prausnitzii, butyrate, and IPA.. Detection efficacy Mouse model Subcutaneous tumor

    Sequencing:

    Article Title: Genistein Pretreatment Attenuates Ovalbumin-Induced Food Allergy in Mice with Intestinal Barrier Preservation and Modulation of Gut Microbiota and Metabolites.
    Article Snippet: .. Genistein (purity > 99%), PEG-300, and OVA peptide (OVA323–339, sequence: ISQAVHAAHAEINEAGR, purity 99.98%, Cat. No. HY-P0286) were obtained from MedChemExpress (Monmouth Junction, NJ, USA). ..

    Isolation:

    Article Title: Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer
    Article Snippet: .. For BMDM and OT-1 CD8 + T cell co-culture, BMDMs from OT-1 mice (8 weeks) were isolated and cultured according to standard methods, and the stimulation reached No. At 5 days, BMDMs were stimulated with OVA peptide (257-264) (SIINFEKL, 1 μg/mL, MCE, HY-P1489) added to TCM for 24 h to induce antigen presentation. ..

    Cell Culture:

    Article Title: Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer
    Article Snippet: .. For BMDM and OT-1 CD8 + T cell co-culture, BMDMs from OT-1 mice (8 weeks) were isolated and cultured according to standard methods, and the stimulation reached No. At 5 days, BMDMs were stimulated with OVA peptide (257-264) (SIINFEKL, 1 μg/mL, MCE, HY-P1489) added to TCM for 24 h to induce antigen presentation. ..

    Immunopeptidomics:

    Article Title: Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer
    Article Snippet: .. For BMDM and OT-1 CD8 + T cell co-culture, BMDMs from OT-1 mice (8 weeks) were isolated and cultured according to standard methods, and the stimulation reached No. At 5 days, BMDMs were stimulated with OVA peptide (257-264) (SIINFEKL, 1 μg/mL, MCE, HY-P1489) added to TCM for 24 h to induce antigen presentation. ..



    Similar Products

    94
    MedChemExpress 15596018cn ova peptide 257 264 invivogen
    15596018cn Ova Peptide 257 264 Invivogen, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p1489a/OVA+Peptide/pm42214334-238-186-194
    Average 94 stars, based on 1 article reviews
    15596018cn ova peptide 257 264 invivogen - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress ova peptide
    Ova Peptide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p1489a/OVA+Peptide/pm42279781-47-6-19
    Average 94 stars, based on 1 article reviews
    ova peptide - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress hy169325 ova peptide medchemexpress
    Hy169325 Ova Peptide Medchemexpress, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p1489a/OVA+Peptide/pm42276047-731-196-199
    Average 94 stars, based on 1 article reviews
    hy169325 ova peptide medchemexpress - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress ot 1 mice
    Validation of GPR34 function in macrophage and CD8 + T cell co-culture system. a Gpr34 flox/flox and Gpr34 Δ Lyz2 mice were treated with anti-CD8α or IgG, followed by orthotopic pancreatic injection of KPC-LUC cells. After tumor formation, chemotherapy was administered to simulate an injury signal. Tumor bioluminescence was dynamically monitored. Representative bioluminescence images show tumor growth in different groups ( n = 6). b Time-course curve of bioluminescence imaging for the KPC-LUC orthotopic model ( n = 6). Two-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance, *** P < 0.001. c Bar plot showing tumor weight on day 21 in the KPC-LUC orthotopic model ( n = 6). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance. d , e BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then co-cultured with TCM and KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells for 24 hours . Flow cytometry analyzed the expression of functional molecules in BMDMs ( d ) and CD8 + T cells ( e ). Bar plots show levels in Gpr34 +/+ vs Gpr34 −/− groups ( n = 3). Two-tailed unpaired Student’s t test was used. Data are presented by mean ± SD. f , g BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, pre-stimulated with SIINFEKL, then cultured with TCM for 12 h, followed by co-culture with CD8 + T cells <t>from</t> <t>OT-1</t> mice for 24 h. Flow cytometry detected T cell-specific killing function ( f ) and BMDM antigen presentation function ( g ). Bar plots show differences between Gpr34 +/+ and Gpr34 −/− groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. h Violin-box plots of cytokine transcript expression in macrophage clusters from scRNA sequencing data. White dot and solid lines in boxes represent medians and quartiles. Two-tailed Wilcoxon test. i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then stimulated with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. qPCR detected Cxcl16 transcript levels. Bar plot compares Cxcl16 transcripts between groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j ELISA detection of cytokine secretion in supernatant from BMDMs stimulated with apoptotic KPC-GFP cells. Bar plot shows CXCL16 protein secretion levels from Gpr34 +/+ and Gpr34 −/− BMDMs ( n = 10). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. k , l BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-cultured with TCM, LysoPS and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells. Flow cytometry detected T cell exhaustion ( k ) and cytotoxicity levels ( l ) ( n = 3). One-way ANOVA with Dunnett’s test compared siRNA groups versus control. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001
    Ot 1 Mice, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p1489a/OVA+Peptide/pmc13121634-612-11-41
    Average 94 stars, based on 1 article reviews
    ot 1 mice - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress ova257 264
    Validation of GPR34 function in macrophage and CD8 + T cell co-culture system. a Gpr34 flox/flox and Gpr34 Δ Lyz2 mice were treated with anti-CD8α or IgG, followed by orthotopic pancreatic injection of KPC-LUC cells. After tumor formation, chemotherapy was administered to simulate an injury signal. Tumor bioluminescence was dynamically monitored. Representative bioluminescence images show tumor growth in different groups ( n = 6). b Time-course curve of bioluminescence imaging for the KPC-LUC orthotopic model ( n = 6). Two-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance, *** P < 0.001. c Bar plot showing tumor weight on day 21 in the KPC-LUC orthotopic model ( n = 6). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance. d , e BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then co-cultured with TCM and KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells for 24 hours . Flow cytometry analyzed the expression of functional molecules in BMDMs ( d ) and CD8 + T cells ( e ). Bar plots show levels in Gpr34 +/+ vs Gpr34 −/− groups ( n = 3). Two-tailed unpaired Student’s t test was used. Data are presented by mean ± SD. f , g BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, pre-stimulated with SIINFEKL, then cultured with TCM for 12 h, followed by co-culture with CD8 + T cells <t>from</t> <t>OT-1</t> mice for 24 h. Flow cytometry detected T cell-specific killing function ( f ) and BMDM antigen presentation function ( g ). Bar plots show differences between Gpr34 +/+ and Gpr34 −/− groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. h Violin-box plots of cytokine transcript expression in macrophage clusters from scRNA sequencing data. White dot and solid lines in boxes represent medians and quartiles. Two-tailed Wilcoxon test. i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then stimulated with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. qPCR detected Cxcl16 transcript levels. Bar plot compares Cxcl16 transcripts between groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j ELISA detection of cytokine secretion in supernatant from BMDMs stimulated with apoptotic KPC-GFP cells. Bar plot shows CXCL16 protein secretion levels from Gpr34 +/+ and Gpr34 −/− BMDMs ( n = 10). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. k , l BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-cultured with TCM, LysoPS and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells. Flow cytometry detected T cell exhaustion ( k ) and cytotoxicity levels ( l ) ( n = 3). One-way ANOVA with Dunnett’s test compared siRNA groups versus control. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001
    Ova257 264, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p1489a/OVA+Peptide/pm40216442-104-32-39
    Average 94 stars, based on 1 article reviews
    ova257 264 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    Image Search Results


    Validation of GPR34 function in macrophage and CD8 + T cell co-culture system. a Gpr34 flox/flox and Gpr34 Δ Lyz2 mice were treated with anti-CD8α or IgG, followed by orthotopic pancreatic injection of KPC-LUC cells. After tumor formation, chemotherapy was administered to simulate an injury signal. Tumor bioluminescence was dynamically monitored. Representative bioluminescence images show tumor growth in different groups ( n = 6). b Time-course curve of bioluminescence imaging for the KPC-LUC orthotopic model ( n = 6). Two-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance, *** P < 0.001. c Bar plot showing tumor weight on day 21 in the KPC-LUC orthotopic model ( n = 6). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance. d , e BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then co-cultured with TCM and KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells for 24 hours . Flow cytometry analyzed the expression of functional molecules in BMDMs ( d ) and CD8 + T cells ( e ). Bar plots show levels in Gpr34 +/+ vs Gpr34 −/− groups ( n = 3). Two-tailed unpaired Student’s t test was used. Data are presented by mean ± SD. f , g BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, pre-stimulated with SIINFEKL, then cultured with TCM for 12 h, followed by co-culture with CD8 + T cells from OT-1 mice for 24 h. Flow cytometry detected T cell-specific killing function ( f ) and BMDM antigen presentation function ( g ). Bar plots show differences between Gpr34 +/+ and Gpr34 −/− groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. h Violin-box plots of cytokine transcript expression in macrophage clusters from scRNA sequencing data. White dot and solid lines in boxes represent medians and quartiles. Two-tailed Wilcoxon test. i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then stimulated with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. qPCR detected Cxcl16 transcript levels. Bar plot compares Cxcl16 transcripts between groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j ELISA detection of cytokine secretion in supernatant from BMDMs stimulated with apoptotic KPC-GFP cells. Bar plot shows CXCL16 protein secretion levels from Gpr34 +/+ and Gpr34 −/− BMDMs ( n = 10). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. k , l BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-cultured with TCM, LysoPS and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells. Flow cytometry detected T cell exhaustion ( k ) and cytotoxicity levels ( l ) ( n = 3). One-way ANOVA with Dunnett’s test compared siRNA groups versus control. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001

    Journal: Signal Transduction and Targeted Therapy

    Article Title: Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer

    doi: 10.1038/s41392-026-02641-4

    Figure Lengend Snippet: Validation of GPR34 function in macrophage and CD8 + T cell co-culture system. a Gpr34 flox/flox and Gpr34 Δ Lyz2 mice were treated with anti-CD8α or IgG, followed by orthotopic pancreatic injection of KPC-LUC cells. After tumor formation, chemotherapy was administered to simulate an injury signal. Tumor bioluminescence was dynamically monitored. Representative bioluminescence images show tumor growth in different groups ( n = 6). b Time-course curve of bioluminescence imaging for the KPC-LUC orthotopic model ( n = 6). Two-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance, *** P < 0.001. c Bar plot showing tumor weight on day 21 in the KPC-LUC orthotopic model ( n = 6). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance. d , e BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then co-cultured with TCM and KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells for 24 hours . Flow cytometry analyzed the expression of functional molecules in BMDMs ( d ) and CD8 + T cells ( e ). Bar plots show levels in Gpr34 +/+ vs Gpr34 −/− groups ( n = 3). Two-tailed unpaired Student’s t test was used. Data are presented by mean ± SD. f , g BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, pre-stimulated with SIINFEKL, then cultured with TCM for 12 h, followed by co-culture with CD8 + T cells from OT-1 mice for 24 h. Flow cytometry detected T cell-specific killing function ( f ) and BMDM antigen presentation function ( g ). Bar plots show differences between Gpr34 +/+ and Gpr34 −/− groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. h Violin-box plots of cytokine transcript expression in macrophage clusters from scRNA sequencing data. White dot and solid lines in boxes represent medians and quartiles. Two-tailed Wilcoxon test. i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then stimulated with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. qPCR detected Cxcl16 transcript levels. Bar plot compares Cxcl16 transcripts between groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j ELISA detection of cytokine secretion in supernatant from BMDMs stimulated with apoptotic KPC-GFP cells. Bar plot shows CXCL16 protein secretion levels from Gpr34 +/+ and Gpr34 −/− BMDMs ( n = 10). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. k , l BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-cultured with TCM, LysoPS and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells. Flow cytometry detected T cell exhaustion ( k ) and cytotoxicity levels ( l ) ( n = 3). One-way ANOVA with Dunnett’s test compared siRNA groups versus control. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001

    Article Snippet: For BMDM and OT-1 CD8 + T cell co-culture, BMDMs from OT-1 mice (8 weeks) were isolated and cultured according to standard methods, and the stimulation reached No. At 5 days, BMDMs were stimulated with OVA peptide (257-264) (SIINFEKL, 1 μg/mL, MCE, HY-P1489) added to TCM for 24 h to induce antigen presentation.

    Techniques: Biomarker Discovery, Co-Culture Assay, Injection, Imaging, Cell Culture, Isolation, Flow Cytometry, Expressing, Functional Assay, Two Tailed Test, Immunopeptidomics, Sequencing, Enzyme-linked Immunosorbent Assay, Transfection, Control